Eurobio Scientific Société anonyme (EPA:ALERS)

France flag France · Delayed Price · Currency is EUR
25.45
0.00 (0.00%)
May 28, 2025, 3:48 PM CET
72.66%
Market Cap 255.38M
Revenue (ttm) 154.95M
Net Income (ttm) 4.00M
Shares Out 10.03M
EPS (ttm) 0.39
PE Ratio 65.34
Forward PE 21.94
Dividend n/a
Ex-Dividend Date n/a
Volume 92
Average Volume 1,847
Open 25.45
Previous Close 25.45
Day's Range 25.45 - 25.45
52-Week Range 13.80 - 26.50
Beta 0.33
RSI 58.02
Earnings Date Jun 24, 2025

About EPA:ALERS

Eurobio Scientific Société anonyme engages in the design, development, and commercialization of in vitro diagnostics products in the areas of transplantation, immunology, infectious diseases, life-science, and cancer. It commercializes media for the transportation and preservation of cornea grafts, as well as a device to facilitate the corresponding surgery; AlloMap, a molecular test for the surveillance of heart-transplant patients; cell culture media, molecular biology reagents, and proprietary antibodies; TQS (Tetanus Quick Stick) for the ev... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 1997
Employees 326
Stock Exchange Euronext Paris
Ticker Symbol ALERS
Full Company Profile

Financial Performance

In 2024, EPA:ALERS's revenue was 154.95 million, an increase of 18.60% compared to the previous year's 130.65 million. Earnings were 4.00 million, a decrease of -17.31%.

Financial Statements

News

There is no news available yet.